Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNA7 | P36544 | 1/20 | 0.34 |
| ▸ | MLKL | Q8NB16 | 1/20 | 0.34 |
| ▸ | ACHE | P22303 | 3/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12791347 | 0.77 | CHRNA7 (0.38) | CHRNA7MLKLACHETDP1ALDH1A1 | |
| SCHEMBL12792015 | 0.77 | CHRNA7 (0.38) | CHRNA7MLKLACHETDP1ALDH1A1 | |
| SCHEMBL12282035 | 0.75 | CHRNA7 (0.37) | CHRNA7MLKLACHETDP1TSHR | |
| SCHEMBL11125030 | 0.71 | ALDH1A1 (0.38) | CHRNA7MLKLACHETDP1ALDH1A1 | |
| SCHEMBL11021620 | 0.67 | CHRNA7 (0.46) | CHRNA7MLKLACHETDP1ALOX5 | |
| SCHEMBL3203986 | 0.67 | ALDH1A1 (0.31) | TDP1ALDH1A1TSHRMAPK1L3MBTL1 | |
| SCHEMBL791847 | 0.66 | MLKL (0.49) | CHRNA7MLKLACHETDP1ALDH1A1 | |
| SCHEMBL2431139 | 0.66 | ACHE (0.44) | CHRNA7MLKLACHETDP1ALDH1A1 | |
| SCHEMBL14615251 | 0.64 | CHRNA7 (0.42) | CHRNA7MLKLACHETDP1ALOX5 | |
| SCHEMBL7615009 | 0.64 | CHRNA7 (0.42) | CHRNA7MLKLACHETDP1ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4720030-A1 | ASYMMETRIC PHENYLALKYLAMINES | Alexander Shulgin Research Institute, Inc. (US) | 2026-04-08 | — | — | EP | disclosed |
| EP-4673430-A2 | PHENYLALKYLAMINE PRODRUGS | Alexander Shulgin Research Institute, Inc. (US) | 2026-01-07 | — | — | EP | disclosed |
| EP-4618981-A1 | COMBINATIONS OF MONOAMINE OXIDASE INHIBITORS AND SEROTONIN RECEPTOR AGONISTS AND THEIR THERAPEUTIC USE | Remedi, Inc. (US) | 2025-09-24 | — | — | EP | disclosed |
| EP-4543833-A1 | N-SUBSTITUTED PHENYLALKYLAMINES AND THEIR USE AS THERAPEUTIC AGENTS | Alexander Shulgin Research Institute, Inc. (US) | 2025-04-30 | — | — | EP | disclosed |
| WO-2024243599-A1 | ASYMMETRIC PHENYLALKYLAMINES | ALEXANDER SHULGIN RESEARCH INSTITUTE, INC. (US) | 2024-11-28 | — | — | WO | disclosed |
| WO-2024182807-A2 | PHENYLALKYLAMINE PRODRUGS | ALEXANDER SHULGIN RESEARCH INSTITUTE, INC. (US) | 2024-09-06 | — | — | WO | disclosed |
| EP-4405318-A1 | SUBSTITUTED PHENYLALKYLAMINES | Alexander Shulgin Research Institute, Inc. (US) | 2024-07-31 | — | — | EP | disclosed |
| WO-2024108195-A1 | COMBINATIONS OF MONOAMINE OXIDASE INHIBITORS AND SEROTONIN RECEPTOR AGONISTS AND THEIR THERAPEUTIC USE | REMEDI, INC. (US) | 2024-05-23 | — | — | WO | disclosed |
| WO-2024091523-A1 | CONFORMATIONALLY RESTRICTED PHENETHYLAMINE ANALOGS | 2A BIOSCIENCES, INC. (US) | 2024-05-02 | — | — | WO | disclosed |
| WO-2024006226-A1 | N-SUBSTITUTED PHENYLALKYLAMINES AND THEIR USE AS THERAPEUTIC AGENTS | ALEXANDER SHULGIN RESEARCH INSTITUTE, INC. (US) | 2024-01-04 | — | — | WO | disclosed |
| WO-2023049480-A1 | SUBSTITUTED PHENYLALKYLAMINES | ALEXANDER SHULGIN RESEARCH INSTITUTE (US) | 2023-03-30 | — | — | WO | disclosed |
| WO-2023283386-A2 | SAFER PSYCHOACTIVE COMPOSITIONS | ARCADIA MEDICINE, INC. (US) | 2023-01-12 | — | — | WO | disclosed |